chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the second dose I noticed that all my lymph nodes got larger and became very painful. I also developed very small bumps on my shoulders that extended down my arm. The specific lymph nodes of concern include a very large one in my left armpit. Two very unusual ones on the left side of my neck above my collarbone. Three very large ones on my stomach. Two along my waistline and 5 large ones on the left side of my back above my kidney. My whole body became very inflamed and I started to gain weight. I became very lethargic and my blood pressure went very high. I was put on a high dose of blood pressure medication. I have always been very athletic and worked out at least once a day. I normally run at least a couple miles every day but after the vaccines I realized that I was to tired to work out or run at all. I started having breathing problems and was wheezing when I breath. My throat felt very tight and I had to try very hard to take normal breaths. I went to the emergency room numerous times for this and they did many tests and labs and images and said everything was normal and sent me home each time. On a daily basis I would develop a blotchy rash on the lower part of my face that extended down my neck onto my shoulders and chest. My throat would swell up and make it very difficult to breath until it went away. I had a lot of trouble sleeping because I would wake up gasping for air 15-20 times a night. My whole body became inflamed and I was constantly in a state of pain. A month or so after the second dose all of my joints started to ache. My shoulders were the worst. They hurt so bad I was not able to use my arms at all some days. I felt constant throbbing sharp pain in both shoulders and pain in all my joints. This went on for about 4-5 months. I began to have random outbreaks of hives on my face and neck. My eyes would become red and swell shut and my throat would swell up so bad I would be gasping for air. I would have chest pains regularly at random. Sometimes I would experience vertigo. I realized that my memory was getting very, very bad and I was having trouble processing thoughts or even putting words together at times.
Felt faint/light-headed, diaphoretic. Pt was placed prone on exam table, pulse and BP assessed WNL - Given water to drink per pt. request. Allowed to rest til he felt better.
mom states that pt had to go to the er due to serious adverse reaction, high fever, feeling badly
Patient developed SVT 15 minutes after receiving vaccine. Admitted to ICU. ER presentation: BP: 160/109 heart rate 132. No e/o anaphylaxis or allergic reaction.
On third day after booster, my arm was swollen and had a horrible rash that was itching badly. My mouth felt like it had blisters all over and my throat was extremely sore. My mouth was so dry I couldn't even talk without a sip of water. I went to the Urgent Care and they gave me a steroid shot and some cream. It helped but my arm is still sore and has a knot on the inside just above bend of my arm. It hurts all the time, I can't lift anything heavy with my arm. Also, I have become allergic to so many things. I can't put anything on my lips except Vaseline. Even plain chapstick makes my lips swell and have a rash on the inside of my mouth, causes dry mouth and itching all over until I take benedryl. I can't drink anything but water and coffee. I can't eat cereal, same thing happens. Anything with cinnamon, same thing happens. There's so many things that does this to my mouth now. I can't  taste anything unless it is very salty or very sweet.
pt recv vax DEC95&pt devel a fever of 104-105;fever abated w/in 48hr;this adverse event may have been previously reported to the FDA on a medwatch form by the reporter
Within 45 minutes of IIV receipt, patient developed face/arm paresthesia, vision changes, shortness of breath, and later, cough and hives on back and arms. She sought evaluation in a civilian emergency room (name unknown, no records available) where she was treated with Epi-pen, Benadryl, Steroids, and an albuterol treatment. Symptoms resolved shortly after treatment, patient was observed several hours before release.  She was prescribed an Epi-pen and later referred to a civilian Allergist/Immunologist. Patient completed allergy skin testing  and no specific allergens identified.  Allergist concerned about overall hyperresponsiveness to many exposures and general reactive airway disease (RAD) symptoms and  prescribed medications for symptom control (Zyrtec, Singulair, Flovent, ProAir HFA).
This case was reported by medical assistant and described a 28 yr old female pt who did not respond to the hep B vaccine recombinant (Engerix B) immunization series. The pt  received three doses of Engerix B on 07Jul03 (lot ENG5379A4), 08Aug03 (lot ENG5390A4) and 09Feb04 (lot ENG5507A4). Engerix B was administered on a 0, 1 and 7 month schedule rather than the recommended schedule of 1, 1, and 6 months. On an unspecified date in May 2004, a hep B surface antibody titer indicated that the pt was non-reactive.
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender who on 15-MAY-2015 was vaccinated with a dose of oral, ROTATEQ (lot # K016313) (expiration date, dose and route not reported) that was 12 hours in temperature excursion. No adverse effects had been observed or reported. This is one of several reports received from the same source. Additional information has been requested.
THE PATIENT STARTED TO HAVE BLURRY VISION AT ABOUT 10 MINUTES AFTER VACCINE, THEN TONGUE IN ONE SPOT ON FRONT TINGLING, STARTED TO GET TINGLING ARM.  BP TAKEN AND AT 151/111 AT 10:45 AM.   CALLED 911, SQUAD TOOK PATIENT AT AMBULANCE AND LEFT PROPERTY
ON DAY OF RECEIVING VACCINE PATIENT HAD SORE ARM AND WAS NAUSEOUS AND HAD CHILLS THROUGHOUT THE REST OF THE DAY FOLLOWING VACCINE ADMINISTRATION AND ALSO THROUGHOUT THE FOLLOWING DAY.
77 years old male with past medical history of A. fib on anticoagulation, glaucoma, prostate cancer on Lupron, arthritis, brought to the emergency room today for confusion and weakness.  The patient reported that his weakness started around 6 AM when he woke up trying to go to pee.  He reported that he was having trouble trying to keep his head up and he was confused as he does not know how to use his phone. However, he has no focal deficit. I believes he may have taken too much of his norco10mg as well. He cannot recall how often he took the med. He also claims to add tylenol 500mg  To the norco 10 to help with his pain.  I believe he call his neighbor and the neighbor called the ambulance and he was brought to the emergency room.     On presentation, his heart rate was 107 but his systolic blood pressure was 93.  Due to history of A. fib and on anticoagulation, the patient had a rectal exam and  guaiac stool   was strongly positive.  He got Kcentra infusion to reverse the Eliquis.   The work-up in the ER showed her the patient has INR 2.12, hemoglobin 11.8, platelet of 70, sodium 131, potassium 4.7, chloride 97, BUN 30 and creatinine 1.3.  There is no chest x-ray, UA or CT scan of the head done.  However, the patient denies any recent head injury.   On the medical floor, the patient continued to be confused but no focal deficit or facial droop.  He is quite confused and his answer is quite tangential.  I spent around 30 minutes trying to get the history and it looks like he has been on new medication for his prostate cancer.  It also sounds like he has been treated with a new medication for his A. fib.  However, it sounds like the patient stopped these medications.  However, he cannot provide me the exact name of the medication nor when he stopped taking them.   It seems like the patient has leg swelling and he has been going on for about 6-week, after he started on the new medication to treat his A. fib.  However, he reported that the medication was not helping his A. fib and he went back to his old medication.  Other than that, his history is quite confusing as he is  Talking mostly about his wife, who is being admitted to another hospital for possible CVA workup...       ROS: Limited but (-) HA, visual changes, f,c,n/v, diarrhea, sob, chestpain, neckpain,  lnew  focal weakness, dysuria, dysphagia, dyspnea.
Almost immediately arm was sore and felt light headed.  Arm grew increasingly uncomfortable.  Small swelling at injection site.   Hard to sleep/lift arm/open car door, etc.  11/4 (day after vaccine) flu-like symptoms started:  flushed face, light headed, nauseas, weak, unable to work, concentrate or participate in normal activities.
One spot of the shingles did show up. He will see the doc next week. The spot size is decreasing. He does not remember the date he noticed the spot. I could not pass that question.
dry cough; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on as second dose single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of Bnt162b2 for covid-19 immunisation. Patient reports he got the second Covid shot a couple days ago and has a dry cough on an unspecified date in May2021. Patient wants to know if that is something regular or valid to have. The outcome of the event was unknown.  Information on batch/ lot number has been requested.
The MA reconstituted sterile diluent with the Acthib powder instead of the sodium chloride diluent and administered vaccine to patient.  The patient did not have any symptoms. After the patient left the clinic is when it was realized how the Acthib was mixed. The manufacture was called and went over the incident & the outcome was that the vaccine given was not valid and would have to be repeated. The manufacture stated that Acthib could be given again as the same day of event. The parent was called and informed of the even that took place & brought the patient back for proper administration of Acthib.  Staff has been trained in reducing healthcare related medical errors by ensuring patient identification, verifying allergies, double checks doses, and ensures other patient safety functions occur as medications are administered to patients.
Client states that late that afternoon she developed numbness of her left cheek.  It felt like she had received novocaine.  She did not call MD, but she took Tylenol. She states it lasted an hour or two hours.
No adverse effects reported; improperly stored doses of VARIVAX and PROQUAD; This spontaneous report was received from an administrator referring to patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 28-MAR-2019 or 31-MAR-2019 or 02-APR-2019 or 03-APR-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) with lot# R023736 with expiration date on 20-AUG-2020 or measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot numbers R008697 and R000551, for prophylaxis (dose and routes of administration). The administered doses of the vaccines experienced temperature excursion -12.85 degrees Celsius for 15 minutes. There was no adverse effect reported.  This call was because of a data logger and there was not previous temperature excursion.   No product quality complaint was involved.   Lot number R008697 and R000551 are invalid lot numbers for  measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) .  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1904USA004740: US-009507513-1904USA004744: US-009507513-1904USA004739: US-009507513-1904USA004741: US-009507513-1904USA004742: US-009507513-1904USA004743:
Received first COVID Vaccine on 02/01/2021 and on 02/18/2021 started with symptoms of sore throat's, cough, chills and achy- seen in clinic on 02/22/2021 and tested positive for COVID 19
On an unspecified date, the pt received her 1st dose of Lymerix and immediately afterwards, the pt had an allergic reaction with generalized rash. She was treated with an unspecified medication. The rash lasted for approximately one week. Lymerix was discontinued. The most recent information, received on 9/7/99, reports the condition of the pt is resolved.
on the morning of 6/3/19 the patient contacted the pharmacy stating she received a shingrix vaccine on the evening of 5/31/19 after which she had to visit the emergency room to seek treatment for pain she noted 10/10. She states emergency room staff conducted imaging studies and she was told she may be suffering from the injection of air into the muscle. She also complained of involuntary movements of the lower extremities after reciving the vaccine. She states she visited her neurologist who upon inspecting her arm noted the vaccine may have been administered too high in the deltoid. the patient states her neurologist has prescribed medications to help improve her conditions but the patient could not tell us which these were.
Patient made appt in clinic next day after appt. Had rash upper torso. Had swelling that was aleviated with Benadryl. Could not conclude that reaction was not from Anthrax
Information has been received from a consumer concerning a 16 month old male who on 8/1/00, was vaccinated with MMR II and DTP. On 8/3/00, the pt developed a red rash that "looked like measles" on his trunk, arms and legs. On 8/4/00, the pt developed diarrhea. The pt's mother reported that the "diarrhea is now chronic with bloody stool". A colonoscopy was performed on 12/29/00, which revealed a dx of lymphnodular hyperplasia, intestines. The pt's mother reported that the pt had no prior history of diarrhea. Upon internal review, the pt's lymphnodular hyperplasia, intestines was considered to be an "Other Medical Event". The pt also developed a runny nose, which has persisted. The pt was treated with Diflucan, starting 10/00, ranitidine starting on 12/29/00 and Zyrtec starting on 12/29/00. Treatment with these therapies continued as of 1/12/01. The consumer reported another child who experienced events following vaccinations with Hep-B vaccine recombinant (yeast) (MSD WAES01011262), MMR II (MSD WAES01011263) and varicella vaccine (MSD WAES01011264). Additional information has been requested.
started off slight headache and sore arm, next day had constipation and extreme abdominal pain including inflammation of entire area.
Subject experienced hives after receiving the vaccine, but is unsure about the time of onset. The symptoms were relieved after taking some medication, and there were no residual symptoms. Patient has a history of allergic reactions and thinks that the hives might have appeared before the vaccination after she tried some new skin lotions that day.
Pt recvd Hep B vax 21JAN91 & that evening pt devel nausea & an edematous & swollen arm; pt went to ER;
pt recvd vax;14nov94 am pt started w/ joint aches(knees & elbows);14nov & 15nov aching cont; 16nov t of 101; 17nov 7am t 98 & 4pm t 102 & aching subsided; 18nov 7am t 98; taking apap & aspirin alternating q 4 hrs;
Sore shoulder at the injection site but days later that subsided. In the next few weeks pain radiated to my left elbow, upper back and neck all on the side of the injection. This continued for weeks. I had two massages to get the toxins circulating again and it has now subsided (3 weeks later)
Swelling at facial filler injection site; Itching at facial filler injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Patients previous medical history included administration of Juvederm facial fillers in lips and cheek.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site). At the time of the report, SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported. No treatment medications were reported.
Site: Pain at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Additional Details: after administration, pt passed out, called emergency number, fire dept treated, pt refused transport to hospital, would take themself to urgent care for follow up
24 hours after Tdap vaccine was adminstered the patient had a significant reaction with entire upper right arm was inflamed and erythematous and warm to the touch. Patient was placed on Bactrim and doxycycline for cellulitis.
Patient arrived to post vaccine area after first dose of Pfizer COVID 19 vaccine. Patient reported feeling some throat "fullness". No rash/hives/redness/swelling, airway clear and patent. Vital signs 144/91 hr 66 O2 100%. Patient reports taking 50mg PO Benadryl 3 hours prior to arrival. Patient seen by MD on site,  given additional 25mg PO Benadryl by physician. MD discussed plan of care with primary care provider. Prescription for PO prednisone arraigned with PCP. Patient monitored for one hour post Benadryl by post vaccine nurse. Reported improvement of symptoms, refused EMS/emergency care/911 services. Confirmed he will be picking up prednisone prescription and will call 911/ seek emergency care if symptoms worsen.   Reported to VAERS by supervisor
Tested NAAT positive for COVID 11/15/21 after being fully vaccinated.
since then I am just been having increasing redness; Swelling; Itching and it''s not stopping; I have pain just like the sore arm as expected; I got my booster done; I got my booster done; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Deltoid Left on 29Sep2021 (Lot Number: FE3592, Expiry date not reported), as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation. Medical history and concomitant medications were not reported.  Historical vaccine included  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as dose 1, single and  on an unspecified date as dose 2, single, both at the age of 32 years for COVID-19 immunization and experienced pain. Nurse stated, "I just want to report a side effect from the booster. I got the Pfizer Covid booster shot and I want to report that I have been having reaction. I got it on Wednesday which was 29Sep2021, I am a healthcare worker so, I got my booster done, then 29 when I got it, since then I am just been having increasing redness, swelling, itching and it's not stopping." The nurse added, "I got it on the 29. I have pain just like the sore arm as expected which I had with the first two and then my booster. I am 32." The patient experienced the events on 29Sep2021. Therapeutic measures were taken for the events redness, swelling, itching and pain in arm that included Benadryl cream, ibuprofen that was for the pain, and pills. Clinical outcome of events redness, swelling, itching and pain in arm was not recovered, while unknown for the other events. The events redness, swelling, itching and pain in arm were reported as serious, medically significant while the other events were non-serious.   Lot number was not provided and will be requested during follow-up.
Patient stated having dizziness and a ?wave of heat? sensation Patient turned car AC on and provided with water, patient stated symptoms resolved Patient seen by medical team , refused medical transport and signed AMA form
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications and drug reactions/ allergies were unknown. On an unspecified date in June 2017, the patient was vaccinated with improperly stored doses of PROQUAD (Lot # M007960, expiration date 15-AUG-2017 or Lot # M049122, expiration date 13-JUN-2018) dose, route were unknown for prophylaxis (the nurse reported that since 02-JUN-2017 this patient and 5 more received the improperly stored doses of vaccine). The lot # and expiration date for the properly stored sterile Water diluent used to reconstitute the doses of PROQUAD was not provided. No adverse effects were reported. The temperature excursion was from 6°F to 14°F for 1 hour, no previous temperature excursion was reported, the call was because a data logger. No product quality complaint was involved. This is one of 6 cases received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA006743: US-009507513-1706USA011000: US-009507513-1706USA011001: US-009507513-1706USA011002: US-009507513-1706USA011003.
Information has been received from a nurse and a healthcare worker, concerning a 52 year old female patient who on an unknown date was vaccinated with a dose of PNEUMOVAX (lot # 654977/0888F), and developed cellulitis.  The symptoms were described as "redness and swelling" with a "lacy appearance and was tender to the touch."  Treatment included VICODIN.  At the time of this report, the outcome of the event was unknown.  The nurse reported that two additional patients, following vaccination with PNEUMOVAX (lot # 654977/0888F), also developed cellulitis (WAES #0709USA02720 and 0709USA03918).  Additional information has been requested.
Made her ill; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of illness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced illness (Verbatim: Made her ill). The outcome of the illness was not reported.   It was unknown if the reporter considered the illness to be related to Shingles vaccine.   It was unknown if the company considered the illness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 14-MAR-2023 This case was reported by a patient's husband via interactive digital media. The patient just got the shingles shot and made her ill but the reporter told her still better than having the shingles like he/she did. The follow up would not possible as no contact details were available.
This spontaneous report was received from an office manager concerning to a patient of unknown age and gender. The patient was vaccinated with lot # (671609/1165AA) Exp. date: 19-OCT-2012 ZOSTAVAX (dose and route not reported) on 17-DEC-2012. No other co-suspects were reported. No concomitant medications were reported. The patient received an expired dose of ZOSTAVAX. No adverse effect reported. No treatment information was reported. The outcome of the event was unknown. Additional information has been requested.